Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
Farmers Insurance
Harvard Business School
Johnson and Johnson
Cipla
Moodys
McKinsey
Cantor Fitzgerald

Generated: June 21, 2018

DrugPatentWatch Database Preview

XYLOCAINE DENTAL WITH EPINEPHRINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Xylocaine Dental With Epinephrine patents expire, and what generic alternatives are available?

Xylocaine Dental With Epinephrine is a drug marketed by Dentsply Pharm and is included in one NDA.

The generic ingredient in XYLOCAINE DENTAL WITH EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for XYLOCAINE DENTAL WITH EPINEPHRINE
Drug patent expirations by year for XYLOCAINE DENTAL WITH EPINEPHRINE

US Patents and Regulatory Information for XYLOCAINE DENTAL WITH EPINEPHRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm XYLOCAINE DENTAL WITH EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 021381-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dentsply Pharm XYLOCAINE DENTAL WITH EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 021381-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Boehringer Ingelheim
Federal Trade Commission
Moodys
Citi
Teva
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.